MedPath

LIDOPRIL

LIDOPRIL ( Lidocaine 2.5% and Prilocaine 2.5% Cream, USP)

Approved
Approval ID

1edfa2e0-8a9a-4c15-8688-61193d75178a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 17, 2016

Manufacturers
FDA

Sterling-knight Pharmaceuticals,LLC

DUNS: 079556942

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine 2.5% and Prilocaine 2.5%

PRODUCT DETAILS

NDC Product Code69336-825
Application NumberNDA019941
Marketing CategoryC73594
Route of AdministrationTOPICAL
Effective DateAugust 16, 2016
Generic NameLidocaine 2.5% and Prilocaine 2.5%

INGREDIENTS (7)

LIDOCAINEActive
Quantity: 25 mg in 1 g
Code: 98PI200987
Classification: ACTIB
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)Inactive
Code: Z135WT9208
Classification: IACT
PRILOCAINEActive
Quantity: 25 mg in 1 g
Code: 046O35D44R
Classification: ACTIB
PEG-55 HYDROGENATED CASTOR OILInactive
Code: 0WZF1506N9
Classification: IACT
CARBOXYPOLYMETHYLENEInactive
Code: 0A5MM307FC
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIDOPRIL - FDA Drug Approval Details